13F Pro quality score
Rank #2,921 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from EyePoint, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $31.4M | $-232.0M | — |
| FY 2024 | 10-K | $43.3M | $-130.9M | — |
| FY 2023 | 10-K | $46.0M | $-70.8M | -163.1% |
| FY 2022 | 10-K | $41.4M | $-102.3M | — |
| FY 2021 | 10-K | $36.9M | $-58.4M | -149.6% |
| FY 2020 | 10-K | $34.4M | $-45.4M | -108.3% |
EyePoint, Inc. (EYPT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EYPT at 4.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,921 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (0.4) and free cash flow (0.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 3.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), EyePoint, Inc. reports quarterly revenue of $507.0K, net income of $-94.5M, free cash flow of $-63.5M. EYPT trades on the Nasdaq exchange and files with the SEC under CIK 1314102. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EYPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EyePoint, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1314102 →